KR20230142816A - 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법 - Google Patents

탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법 Download PDF

Info

Publication number
KR20230142816A
KR20230142816A KR1020237033481A KR20237033481A KR20230142816A KR 20230142816 A KR20230142816 A KR 20230142816A KR 1020237033481 A KR1020237033481 A KR 1020237033481A KR 20237033481 A KR20237033481 A KR 20237033481A KR 20230142816 A KR20230142816 A KR 20230142816A
Authority
KR
South Korea
Prior art keywords
drug
silicone
lumen
bladder
drug delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020237033481A
Other languages
English (en)
Korean (ko)
Inventor
이희진
카렌 다니엘
Original Assignee
타리스 바이오메디컬 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 타리스 바이오메디컬 엘엘씨 filed Critical 타리스 바이오메디컬 엘엘씨
Publication of KR20230142816A publication Critical patent/KR20230142816A/ko
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/0009—Making of catheters or other medical or surgical tubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0216—Materials providing elastic properties, e.g. for facilitating deformation and avoid breaking
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2207/00—Methods of manufacture, assembly or production
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/10—Trunk
    • A61M2210/1078—Urinary tract
    • A61M2210/1085—Bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
KR1020237033481A 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법 Pending KR20230142816A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201462017775P 2014-06-26 2014-06-26
US62/017,775 2014-06-26
PCT/US2015/037887 WO2015200752A1 (en) 2014-06-26 2015-06-26 Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
KR1020227013798A KR20220061253A (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020227013798A Division KR20220061253A (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법

Publications (1)

Publication Number Publication Date
KR20230142816A true KR20230142816A (ko) 2023-10-11

Family

ID=53524992

Family Applications (4)

Application Number Title Priority Date Filing Date
KR1020237033481A Pending KR20230142816A (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
KR1020227013799A Active KR102486216B1 (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
KR1020177000765A Active KR102391761B1 (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
KR1020227013798A Ceased KR20220061253A (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법

Family Applications After (3)

Application Number Title Priority Date Filing Date
KR1020227013799A Active KR102486216B1 (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
KR1020177000765A Active KR102391761B1 (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법
KR1020227013798A Ceased KR20220061253A (ko) 2014-06-26 2015-06-26 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법

Country Status (9)

Country Link
US (3) US10737078B2 (enExample)
EP (3) EP3160442B1 (enExample)
JP (3) JP6856380B2 (enExample)
KR (4) KR20230142816A (enExample)
CN (2) CN114306899A (enExample)
AU (4) AU2015279674B2 (enExample)
DK (1) DK3160442T3 (enExample)
ES (2) ES2728504T3 (enExample)
WO (1) WO2015200752A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT3113782T (pt) 2014-03-06 2023-01-05 Taris Biomedical Llc Sistemas e métodos de administração de fármaco para tratamento do cancro da bexiga com gemcitabina
US20180117219A1 (en) * 2015-04-29 2018-05-03 Northwestern University 3d printing of biomedical implants
US11185670B2 (en) 2016-01-26 2021-11-30 Taris Biomedical Llc Multi-lumen drug delivery devices
SG11201809838VA (en) 2016-05-06 2018-12-28 Taris Biomedical Llc Method of treating lower tract urothelial cancer
US10857173B2 (en) 2017-07-25 2020-12-08 Taris Biomedical Llc Methods of treating tumor metastasis
KR102892737B1 (ko) 2017-11-08 2025-11-28 타리스 바이오메디컬 엘엘씨 젬시타빈을 사용한 방광암의 치료 및 유지 요법의 방법
WO2019232292A1 (en) 2018-05-31 2019-12-05 Massachusetts Institute Of Technology Resident articles for gram-level dosing
AU2019315957A1 (en) 2018-08-01 2021-02-18 Taris Biomedical Llc Methods of treating overactive bladder using trospium
EA202191310A1 (ru) * 2018-11-09 2021-09-16 ТЭРИС БАЙОМЕДИКАЛ ЭлЭлСи Устройства доставки лекарственного средства и системы для местной доставки лекарственных средств в верхние мочевыводящие пути
JP2023543267A (ja) * 2020-09-28 2023-10-13 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア アパルタミドを含有する薬物インプラント及びその使用方法
EP4452385B1 (en) 2021-12-21 2026-02-11 TARIS Biomedical LLC Urinary placement catheter for intravesical devices
CN115120854B (zh) * 2022-07-04 2023-10-13 奥格生物技术（六安）有限公司 前列腺自然直接给药装置
CN119698271A (zh) * 2022-07-20 2025-03-25 加利福尼亚大学董事会 含有达罗他胺的药物植入物及其使用方法
WO2024092159A1 (en) 2022-10-28 2024-05-02 Taris Biomedical Llc Methods of treating bladder cancer with gemcitabine
EP4694895A1 (en) 2023-04-10 2026-02-18 TARIS Biomedical LLC Gemcitabine for use in methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guerin therapy
AU2024356379A1 (en) 2023-10-02 2026-05-14 Janssen Biotech, Inc. Methods of treating high-risk non-muscle invasive bladder cancer unresponsive to bacillus calmette-guérin therapy

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3854480A (en) * 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3967618A (en) * 1969-04-01 1976-07-06 Alza Corporation Drug delivery device
US4871542A (en) 1987-04-30 1989-10-03 Ferring Service Center, N.V. Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract
NZ228382A (en) * 1989-03-17 1992-08-26 Carter Holt Harvey Plastic Pro Drug administering coil-like device for insertion in body cavity of animal
FI95768C (fi) * 1993-06-17 1996-03-25 Leiras Oy Emättimensisäinen antosysteemi
US20060052757A1 (en) * 1996-06-04 2006-03-09 Vance Products Incorporated, D/B/A Cook Urological Incorporated Implantable medical device with analgesic or anesthetic
US20070161968A1 (en) * 1996-06-04 2007-07-12 Vance Products Inc., Dba Cood Urological Inc. Implantable medical device with pharmacologically active ingredient
US20060025726A1 (en) * 1996-06-04 2006-02-02 Vance Products Incorporated, D/B/A Cook Urological Incorporated Implantable medical device with pharmacologically active layer
AU6876498A (en) 1997-04-03 1998-10-22 Point Biomedical Corporation Intravesical drug delivery system
US6183461B1 (en) 1998-03-11 2001-02-06 Situs Corporation Method for delivering a medication
US7077859B2 (en) 2000-12-22 2006-07-18 Avantec Vascular Corporation Apparatus and methods for variably controlled substance delivery from implanted prostheses
US6752829B2 (en) 2001-01-30 2004-06-22 Scimed Life Systems, Inc. Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same
MX2013000002A (es) 2001-07-27 2013-04-29 Teva Womens Health Inc Metodos de tratamiento de condiciones patologicas asociadas con vejiga hiperactiva.
US8685427B2 (en) * 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
US7166133B2 (en) * 2002-06-13 2007-01-23 Kensey Nash Corporation Devices and methods for treating defects in the tissue of a living being
DE10247689A1 (de) 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
US6926735B2 (en) 2002-12-23 2005-08-09 Scimed Life Systems, Inc. Multi-lumen vascular grafts having improved self-sealing properties
US7288084B2 (en) * 2003-04-28 2007-10-30 Boston Scientific Scimed, Inc. Drug-loaded medical device
EP1933810B1 (en) 2005-08-11 2012-10-10 Massachusetts Institute of Technology Intravesical drug delivery device and method
US20080311172A1 (en) * 2007-04-25 2008-12-18 Schapira Jay N Programmed-release, nanostructured biological construct
EA201070703A1 (ru) * 2007-12-11 2010-12-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарства и способы лечения мочевого пузыря и других полостей тела или трубчатых органов
EA201170297A1 (ru) 2008-08-09 2011-08-30 Массачусетс Инститьют Оф Текнолоджи Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей
FI121000B (fi) * 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginaalinen antojärjestelmä ja menetelmä sen valmistamiseksi
CA2765630C (en) * 2009-06-26 2016-07-05 Taris Biomedical, Inc. Solid drug tablets for implantable drug delivery devices
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
AU2010339821B2 (en) * 2009-12-17 2015-02-19 Taris Biomedical Llc Implantable device with intravesical tolerability and methods of treatment
US9492266B2 (en) 2010-08-05 2016-11-15 Taris Biomedical Llc Ureteral stent drug delivery device, kit, and method
ES2822118T3 (es) 2010-08-05 2021-04-29 Taris Biomedical Llc Dispositivos de administración de fármacos implantables para sitios genitourinarios
WO2012048114A1 (en) 2010-10-06 2012-04-12 Taris Biomedical, Inc. Time-selective bioresorbable or collapsible drug delivery systems and methods
WO2012048104A1 (en) * 2010-10-06 2012-04-12 Taris Biomedical, Inc. Implantable drug delivery device with bladden retention feature
ES2637388T3 (es) 2011-02-04 2017-10-13 Taris Biomedical, Inc. Dispositivo implantable para la liberación controlada de un fármaco de baja solubilidad
BR112014001450A2 (pt) 2011-07-20 2017-07-18 F Kiser Patrick dispositivos intravaginais para distribuição de droga
US10058688B2 (en) 2012-05-09 2018-08-28 Massachusetts Institute Of Technology Medicament, method, and drug delivery device for treatment of ovarian cancer
ES3015082T3 (en) * 2012-05-19 2025-04-29 Taris Biomedical Llc Implantable urological device with retrieval feature
PL2968880T3 (pl) 2013-03-15 2025-06-23 Taris Biomedical Llc Urządzenia do dostarczania leku ze składnikiem przepuszczalnym dla leku
MX391755B (es) 2013-03-15 2025-03-21 Taris Biomedical Llc Dispositivos de administración de medicamentos y métodos para administración de medicamentos.
IL299897B2 (en) 2013-08-19 2024-02-01 Taris Biomedical Llc Devices and methods for administering multiple units of drug
AU2015259361B2 (en) 2014-05-12 2020-11-05 Taris Biomedical Llc Drug delivery devices and methods
EP4744688A2 (en) 2015-04-23 2026-05-20 Janssen Biotech Inc DRUG DELIVERY DEVICES WITH A DRUG-PERMEABLE COMPONENT AND METHODS

Also Published As

Publication number Publication date
KR20220061254A (ko) 2022-05-12
US20200368509A1 (en) 2020-11-26
EP4173615A2 (en) 2023-05-03
KR102486216B1 (ko) 2023-01-09
AU2024204468B2 (en) 2026-02-26
CN106456951B (zh) 2021-11-05
JP2020110615A (ja) 2020-07-27
KR20170026465A (ko) 2017-03-08
AU2020250209B2 (en) 2022-07-14
US11904123B2 (en) 2024-02-20
EP3517099A1 (en) 2019-07-31
JP2017524421A (ja) 2017-08-31
US12239807B2 (en) 2025-03-04
DK3160442T3 (da) 2019-06-11
ES2728504T3 (es) 2019-10-25
CN106456951A (zh) 2017-02-22
AU2024204468A1 (en) 2024-07-18
WO2015200752A8 (en) 2016-08-11
JP2022022292A (ja) 2022-02-03
JP6856380B2 (ja) 2021-04-07
ES2940478T3 (es) 2023-05-08
AU2015279674A1 (en) 2017-01-12
EP3160442A1 (en) 2017-05-03
CN114306899A (zh) 2022-04-12
AU2020250209A1 (en) 2020-11-05
WO2015200752A1 (en) 2015-12-30
EP3160442B1 (en) 2019-03-06
EP3517099B1 (en) 2022-12-28
KR102391761B1 (ko) 2022-04-27
AU2022204523A1 (en) 2022-07-21
US10737078B2 (en) 2020-08-11
EP4173615A3 (en) 2023-07-19
US20200368508A1 (en) 2020-11-26
AU2015279674B2 (en) 2020-07-23
AU2022204523B2 (en) 2024-05-16
US20170165460A1 (en) 2017-06-15
KR20220061253A (ko) 2022-05-12
JP7005668B2 (ja) 2022-01-21

Similar Documents

Publication Publication Date Title
AU2022204523B2 (en) Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
US20250381375A1 (en) Drug Delivery Device with Drug-Permeable Component
US11992583B2 (en) Drug delivery devices and methods
JP2024028930A (ja) 薬物透過性構成要素を有する薬物送達デバイス及び方法
AU2026203471A1 (en) Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
HK40092575A (en) Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
US20170246437A1 (en) pH-MODULATING DRUG DELIVERY DEVICES AND METHODS
HK40072987A (en) Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
HK40047951A (en) Drug delivery devices

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

D21 Rejection of application intended

Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D21-EXM-PE0902 (AS PROVIDED BY THE NATIONAL OFFICE)

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000